Search

Search Constraints

You searched for: Author/Creator Fleming, Jason B.

Search Results

21. Prognostic Significance of New AJCC Tumor Stage in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Therapy. (August 2017)

22. Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy. Issue 9 (October 2017)

23. Racial and ethnic disparities in a state‐wide registry of patients with pancreatic cancer and an exploratory investigation of cancer cachexia as a contributor to observed inequities. (9th May 2019)

24. Selective efficacy of zoledronic acid on metastasis in a patient‐derived orthotopic xenograph (PDOX) nude‐mouse model of human pancreatic cancer. Issue 3 (14th November 2014)

25. Serum carbohydrate antigen 19‐9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer. Issue 5 (29th August 2013)

27. Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy. (March 2018)

28. Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma. (October 2015)

29. Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma. (October 2015)

30. The effect of histologic grade on neoadjuvant treatment outcomes in esophageal cancer. Issue 3 (16th May 2022)